Advanced search
Publication Cover
Cancer Investigation Volume 27, 2009 - Issue 6
Submit an article Journal homepage
114
Views
14
CrossRef citations to date
0
Altmetric
COMMENTARY

Comparative Effectiveness Research in Oncology: The Need for Clarity, Transparency and Vision

Gary H. Lyman Effectiveness and Outcomes Research, Duke University and the Duke Comprehensive Cancer Center, Duke Center for Clinical Health Policy Research, and member of the Oncology Drug Advisory Committee to the US Food and Drug Administration
, M.D., M.P.H., F.R.C.P. (Edin)
Pages 593-597 | Published online: 20 Jul 2009

REFERENCES

  • Boyle P., Levin B. World Cancer Report: 2008. Lyon, International Agency for Research on Cancer 2008
  • Somerfield M. R., Einhaus K., Hagerty K. L., et al. American Society of Clinical Oncology clinical practice guidelines: opportunities and challenges. J Clin Oncol 2008; 26: 4022–4026
  • Riley R. D., Sauerbrei W., Altman D. G. Prognostic markers in cancer: the evolution of evidence from single studies to meta-analysis, and beyond. Br J Cancer 2009; 100: 1219–1229
  • Altman D. G., Lyman G. H. Methodological challenges in the evaluation of prognostic factors in breast cancer. Breast Cancer Res Treat 1998; 52: 289–303
  • Paik S., Shak S., Tang G., et al. A multigene assay to predict recurrence of tamoxifen-treated, node negative breast cancer. N Engl J Med 2004; 351: 2817–2826
  • Paik S., Tang G., Shak S., et al. Gene expression and benefit of chemotherapy in women with node negative, estrogen receptor-positive breast cancer. J Clin Oncol 2006; 24: 3726–3734
  • Lyman G. H., Kuderer N. M. Gene expression profile assays as predictors of recurrence-free survival in early-stage breast cancer: a metaanalysis. Clin Breast Cancer 2006; 7: 372–379
  • Hornberger J., Cosler L. E., Lyman G. H. Economic analysis of targeting chemotherapy using a 21-gene RT-PCR assay in lymph-node negative, estrogen-receptor-positive, early-stage breast cancer. Am J Manag Care 2005; 11: 313–324
  • Lyman G. H., Cosler L. E., Kuderer N. M., et al. Impact of a 21-gene RT-PCR assay on treatment decisions in early-stage breast cancer: an economic analysis based on prognostic and predictive validation studies. Cancer 2007; 109: 1011–1018
  • McShane L. M., Altman D. G., Sauerbrei W., et al. Reporting recommendations for tumor marker prognostic studies (REMARK). J Natl Cancer Inst 2005; 97: 1180–1184
  • Allegra C. J., Jessup J. M., Somerfield M. R., et al. American Society of Clinical Oncology provisional clinical opinion: testing for KRAS gene mutations in patients with metastatic colorectal carcinoma to predict response to anti-epidermal growth factor receptor monoclonal antibody therapy. J Clin Oncol 2009; 27: 2091–2096
  • Teutsch S. M., Bradley L. A., Palomaki G. E., et al. The Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Initiative: methods of the EGAPP Working Group. Genet Med 2009; 11: 3–14

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.